High level of lncRNA H19 expression is associated with shorter survival in esophageal squamous cell cancer patients-Reference-Cited by-同舟云学术

High level of lncRNA H19 expression is associated with shorter survival in esophageal squamous cell cancer patients

Published:2019-11 Issue:11 Volume:215 Page:152638
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Li Xiangyu,Yang Haijun,Wang Jianbo,Li Xiufang,Fan Zhirui,Zhao Jing,Liu Lan,Zhang Mingzhi,Goscinski Mariusz Adam,Wang Junsheng,Xu Ruiping,Fan Huijie,Li Huixiang,Suo Zhenhe

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference35 articles.

1. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries;Domper Arnal;World J. Gastroenterol.,2015

2. From blood to breath: new horizons for esophageal cancer biomarkers;Yazbeck;World J. Gastroenterol.,2016

3. Global incidence of oesophageal cancer by histological subtype in 2012;Arnold;Gut,2015

4. The emergence of lncRNAs in cancer biology;Prensner;Cancer Discov.,2011

5. c. S chmitt AM.Long Non coding RNAs in Can cer Pathways.Can cer Cell 2016;29:452-463.DOI:10.1016/j.c cell.2016.03.010.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Nucleotide Polymorphisms (SNPs) in the Shadows: Uncovering their Function in Non-Coding Region of Esophageal Cancer;Current Pharmaceutical Biotechnology;2024-11

2. Unraveling the ncRNA landscape that governs colorectal cancer: A roadmap to personalized therapeutics;Life Sciences;2024-10

3. Critical roles of long noncoding RNA H19 in cancer;Cell Biochemistry and Function;2024-04

4. Prognostic value of circulating long non-coding RNAs in colorectal cancer patients: a meta-analysis;Expert Review of Anticancer Therapy;2023-11-07

5. THE EXPRESSION OF ANNEXIN-A1 IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA AND ITS ASSOCIATION WITH THE BIOLOGICAL BEHAVIOR OF THE PRIMARY HUMAN ESOPHAGEAL SQUAMOUS CARCINOMA CELL LINE;J PHYSIOL PHARMACOL;2023